Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

12.71
Data as of Sep 23
 -0.28 / -2.16%
Today’s Change
8.61
Today|||52-Week Range
18.48
-1.85%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 24.00, with a high estimate of 32.00 and a low estimate of 14.00. The median estimate represents a +88.83% increase from the last price of 12.71.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$138.4K
Reporting Date
Nov 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.23%
 
 
 
 
 
 
Growthannually -53.29%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 133.57%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.